In vitro activity of fosfomycin in combination with colistin against clinical isolates of carbapenem-resistant Pseudomas aeruginosa

Nature·Mar 25

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Research is being conducted on combination therapies to combat carbapenem-resistant bacteria, including Pseudomonas aeruginosa. Studies are examining the in vitro and in vivo efficacy of various antibiotic combinations, such as fosfomycin with colistin, against multidrug-resistant pathogens. The effectiveness of these combinations against different types of carbapenem-resistant bacteria, including Acinetobacter baumannii and Klebsiella pneumoniae, is being investigated.

Full coverage

Overcoming the drug resistance barrier: progress in fosfomycin combination therapy against multidrug-resistant pathogens

Frontiers·Nov 17

In vitro activity of sulbactam in combination with other antimicrobial agents against extensively drug-resistant Acinetobacter baumannii

ASM Journals·Aug 12

Synergistic antibacterial activity of ceftazidime–avibactam in combination with colistin, gentamicin, amikacin, and fosfomycin against carbapenem-resistant Klebsiella pneumoniae | Scientific Reports

Nature·Jul 30

Current progress in antibacterial agents for carbapenem-resistant enterobacterales

Frontiers·Mar 9

Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant Organisms

NEJM Evidence·Dec 6

In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia

Nature·Nov 20

Efficacy of Antibiotic Combinations against Multidrug-Resistant Pseudomonas aeruginosa in Automated Time-Lapse Microscopy and Static Time-Kill Experiments

ASM Journals·Aug 4

Treatment of infections caused by carbapenem-resistant Acinetobacter baumannii

Frontiers·Jul 18

View original report at Nature ↗

Fetching the latest headlines…